University of Oxford's Kennedy Institute of Rheumatology Partners with Absci to Accelerate AI-Driven Immunotherapies

Author's Avatar
May 11, 2023

Absci will apply its generative AI platform to The Kennedy Institute’s immunology biorepository to speed the discovery and development of multiple therapies